As of 2026-03-21, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 368.08 USD. This relative valuation is based on P/E multiples. With the latest stock price at 454.00 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -18.9%.
The range of the Relative Valuation is 277.63 - 432.00 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 27.8x | 23.7x |
| Forward P/E multiples | 20.5x - 24.2x | 22.8x |
| Fair Price | 277.63 - 432.00 | 368.08 |
| Upside | -38.8% - -4.8% | -18.9% |
| Date | P/E |
| 2026-03-20 | 29.17 |
| 2026-03-19 | 29.43 |
| 2026-03-18 | 29.02 |
| 2026-03-17 | 29.72 |
| 2026-03-16 | 29.95 |
| 2026-03-13 | 30.16 |
| 2026-03-12 | 30.72 |
| 2026-03-11 | 31.64 |
| 2026-03-10 | 32.08 |
| 2026-03-09 | 29.62 |
| 2026-03-06 | 29.35 |
| 2026-03-05 | 29.61 |
| 2026-03-04 | 30.71 |
| 2026-03-03 | 30.48 |
| 2026-03-02 | 31.23 |
| 2026-02-27 | 31.93 |
| 2026-02-26 | 30.85 |
| 2026-02-25 | 31.04 |
| 2026-02-24 | 31.32 |
| 2026-02-23 | 30.91 |
| 2026-02-20 | 30.65 |
| 2026-02-19 | 30.15 |
| 2026-02-18 | 30.22 |
| 2026-02-17 | 30.67 |
| 2026-02-13 | 31.58 |
| 2026-02-12 | 29.88 |
| 2026-02-11 | 29.64 |
| 2026-02-10 | 29.78 |
| 2026-02-09 | 30.26 |
| 2026-02-06 | 30.71 |
| 2026-02-05 | 29.48 |
| 2026-02-04 | 30.24 |
| 2026-02-03 | 29.92 |
| 2026-02-02 | 30.33 |
| 2026-01-30 | 30.20 |
| 2026-01-29 | 30.57 |
| 2026-01-28 | 30.71 |
| 2026-01-27 | 30.47 |
| 2026-01-26 | 30.64 |
| 2026-01-23 | 30.10 |
| 2026-01-22 | 30.03 |
| 2026-01-21 | 29.63 |
| 2026-01-20 | 28.41 |
| 2026-01-16 | 28.36 |
| 2026-01-15 | 28.20 |
| 2026-01-14 | 28.89 |
| 2026-01-13 | 29.22 |
| 2026-01-12 | 29.60 |
| 2026-01-09 | 29.81 |
| 2026-01-08 | 30.18 |